English

Benchmark Success, Clinical Failure: When Reinforcement Learning Optimizes for Benchmarks, Not Patients

Artificial Intelligence 2026-01-05 v2 Machine Learning

Abstract

Recent Reinforcement Learning (RL) advances for Large Language Models (LLMs) have improved reasoning tasks, yet their resource-constrained application to medical imaging remains underexplored. We introduce ChexReason, a vision-language model trained via R1-style methodology (SFT followed by GRPO) using only 2,000 SFT samples, 1,000 RL samples, and a single A100 GPU. Evaluations on CheXpert and NIH benchmarks reveal a fundamental tension: GRPO recovers in-distribution performance (23% improvement on CheXpert, macro-F1 = 0.346) but degrades cross-dataset transferability (19% drop on NIH). This mirrors high-resource models like NV-Reason-CXR-3B, suggesting the issue stems from the RL paradigm rather than scale. We identify a generalization paradox where the SFT checkpoint uniquely improves on NIH before optimization, indicating teacher-guided reasoning captures more institution-agnostic features. Furthermore, cross-model comparisons show structured reasoning scaffolds benefit general-purpose VLMs but offer minimal gain for medically pre-trained models. Consequently, curated supervised fine-tuning may outperform aggressive RL for clinical deployment requiring robustness across diverse populations.

Keywords

Cite

@article{arxiv.2512.23090,
  title  = {Benchmark Success, Clinical Failure: When Reinforcement Learning Optimizes for Benchmarks, Not Patients},
  author = {Armin Berger and Manuela Bergau and Helen Schneider and Saad Ahmad and Tom Anglim Lagones and Gianluca Brugnara and Martha Foltyn-Dumitru and Kai Schlamp and Philipp Vollmuth and Rafet Sifa},
  journal= {arXiv preprint arXiv:2512.23090},
  year   = {2026}
}
R2 v1 2026-07-01T08:43:41.288Z